Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Services » Servicestothe Health Industry
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| DGX | Quest Diagnostics, Inc. | 2.23% | 111.62 | 4.3% | $193.93m | |
| IQV | IQVIA Holdings, Inc. | 2.24% | 151.39 | 0.0% | $166.97m | |
| LH | Laboratory Corp. of America Holdings | 1.74% | 180.94 | 2.4% | $147.86m | |
| SYNH | Syneos Health, Inc. | 0.57% | 51.58 | 0.0% | $48.40m | |
| AMEH | Apollo Medical Holdings, Inc. | 2.31% | 16.86 | 0.0% | $3.02m | |
| NRC | National Research Corp. | 0.45% | 46.95 | 0.0% | $1.44m | |
| IDXG | Interpace Biosciences, Inc. | 3.00% | 3.09 | 22.8% | $0.57m | |
| PLX | Protalix Biotherapeutics, Inc. | -0.28% | 3.63 | 26.0% | $0.29m | |
| PMD | Psychemedics Corp. | -0.46% | 4.33 | 0.7% | $0.11m | |
| BASI | Bioanalytical Systems, Inc. | 0.62% | 4.86 | 0.2% | $0.07m |
Company Profile
Bioanalytical Systems, Inc. operates as a pharmaceutical development company, which engages in the provision of drug discovery, development services, and analytical instruments. The firm operates through the following business segments: Contract Research Services and Research Products. The Contract Research Services segment provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance, and quality control testing. The Research Products segment designs, develops, manufactures, and markets vivo sampling systems and accessories, physiology monitoring tools, liquid chromatography, and electrochemistry instruments platforms. The company was founded by Peter T. Kissinger in 1974 and is headquartered in West Lafayette, IN.